These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 24000874)
21. [The benefit of angiotensin converting enzyme inhibitor for geriatric syndrome in the elderly]. Ebihara T; Ohrui T; Ebihara S; Tsuji I; Sasaki H; Arai H Nihon Ronen Igakkai Zasshi; 2007 Jul; 44(4):448-51. PubMed ID: 17827800 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease. Chou PS; Wu MN; Chou MC; Chien I; Yang YH Geriatr Gerontol Int; 2017 Oct; 17(10):1544-1550. PubMed ID: 27862810 [TBL] [Abstract][Full Text] [Related]
23. [Behavioral and psychologic symptoms in Alzheimer's disease: results of the REAL.FR study]. Benoit M; Staccini P; Brocker P; Benhamidat T; Bertogliati C; Lechowski L; Tortrat D; Robert PH Rev Med Interne; 2003 Oct; 24 Suppl 3():319s-324s. PubMed ID: 14710451 [TBL] [Abstract][Full Text] [Related]
24. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease. Droogsma E; van Asselt D; Diekhuis M; Veeger N; van der Hooft C; De Deyn PP Int Psychogeriatr; 2015 Aug; 27(8):1323-33. PubMed ID: 25779465 [TBL] [Abstract][Full Text] [Related]
25. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group). Guerin O; Soto ME; Brocker P; Robert PH; Benoit M; Vellas B; J Nutr Health Aging; 2005; 9(2):81-4. PubMed ID: 15791350 [TBL] [Abstract][Full Text] [Related]
26. Frailty Index and Cognitive Decline in Alzheimer's Disease: Data from the Impact of Cholinergic Treatment USe Study. Kelaiditi E; Canevelli M; Andrieu S; Del Campo N; Soto ME; Vellas B; Cesari M; J Am Geriatr Soc; 2016 Jun; 64(6):1165-70. PubMed ID: 27321595 [TBL] [Abstract][Full Text] [Related]
27. Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians. Del Campo N; Cesari M; Canevelli M; Hoogendijk EO; Lilamand M; Kelaiditi E; Soto ME; Ousset PJ; Weiner MW; Andrieu S; Vellas B; J Am Med Dir Assoc; 2016 Oct; 17(10):913-20. PubMed ID: 27670604 [TBL] [Abstract][Full Text] [Related]
28. The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women. Yasar S; Zhou J; Varadhan R; Carlson MC Clin Pharmacol Ther; 2008 Jul; 84(1):119-26. PubMed ID: 18231116 [TBL] [Abstract][Full Text] [Related]
29. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice. Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831 [TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Solfrizzi V; Scafato E; Frisardi V; Seripa D; Logroscino G; Kehoe PG; Imbimbo BP; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Pilotto A; Panza F; Age (Dordr); 2013 Apr; 35(2):441-53. PubMed ID: 22203459 [TBL] [Abstract][Full Text] [Related]
31. The mini-mental state examination, clinical factors, and motor vehicle crash risk. Joseph PG; O'Donnell MJ; Teo KK; Gao P; Anderson C; Probstfield JL; Bosch J; Khatib R; Yusuf S J Am Geriatr Soc; 2014 Aug; 62(8):1419-26. PubMed ID: 25040793 [TBL] [Abstract][Full Text] [Related]
32. Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease. Yamada K; Uchida S; Takahashi S; Takayama M; Nagata Y; Suzuki N; Shirakura S; Kanda T Brain Res; 2010 Sep; 1352():176-86. PubMed ID: 20627092 [TBL] [Abstract][Full Text] [Related]
33. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study. Sourdet S; van Kan GA; Soto ME; Houles M; Cantet C; Nourhashemi F; Vellas B; Pahor M; Rolland Y J Am Med Dir Assoc; 2012 May; 13(4):407.e1-6. PubMed ID: 22227074 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA; Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study. Hajjar IM; Keown M; Lewis P; Almor A Am J Alzheimers Dis Other Demen; 2008; 23(1):77-83. PubMed ID: 18276960 [TBL] [Abstract][Full Text] [Related]
37. [Clinical presentation of Moroccan cases with Alzheimer's disease]. El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896 [TBL] [Abstract][Full Text] [Related]
38. Living Alone with Alzheimer's Disease and the Risk of Adverse Outcomes: Results from the Plan de Soin et d'Aide dans la maladie d'Alzheimer Study. Soto M; Andrieu S; Gares V; Cesari M; Gillette-Guyonnet S; Cantet C; Vellas B; Nourhashémi F J Am Geriatr Soc; 2015 Apr; 63(4):651-8. PubMed ID: 25900483 [TBL] [Abstract][Full Text] [Related]
39. Memory is preserved in older adults taking AT1 receptor blockers. Ho JK; Nation DA; Alzheimers Res Ther; 2017 Apr; 9(1):33. PubMed ID: 28446207 [TBL] [Abstract][Full Text] [Related]
40. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease. Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B; Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]